ANUH PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 247.4 INR | +2.42% |
|
+5.59% | +68.79% |
| 04-08 | Anuh Pharma Limited Approves Final Dividend for the Financial Year Ended 2022-2023 | CI |
| 04-04 | Anuh Pharma Limited Appoints Manan Jayesh Vadhan as Company Secretary and Compliance Officer | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,923 | 3,388 | 2,920 | 4,525 | 4,307 | 3,990 |
| Enterprise Value (EV) 1 | 3,553 | 3,273 | 2,695 | 4,530 | 4,097 | 3,468 |
| P/E ratio | 23.8 x | 14.5 x | 20.4 x | 15.9 x | 14.1 x | 11 x |
| Yield | 1.76% | 2.03% | 2.36% | 1.66% | 2.04% | 2.51% |
| Capitalization / Revenue | 1.65 x | 1.06 x | 0.95 x | 1.05 x | 0.89 x | 0.76 x |
| EV / Revenue | 1.49 x | 1.02 x | 0.88 x | 1.05 x | 0.84 x | 0.66 x |
| EV / EBITDA | 17.7 x | 9.59 x | 9.18 x | 10.3 x | 8.51 x | 6.53 x |
| EV / FCF | -57.7 x | -22.9 x | 19.8 x | -13.1 x | 16.1 x | 7.24 x |
| FCF Yield | -1.73% | -4.37% | 5.04% | -7.65% | 6.22% | 13.8% |
| Price to Book | 2.62 x | 2.06 x | 1.8 x | 2.37 x | 2.01 x | 1.65 x |
| Nbr of stocks (in thousands) | 50,112 | 50,112 | 50,112 | 50,112 | 50,112 | 50,112 |
| Reference price 2 | 78.28 | 67.60 | 58.28 | 90.30 | 85.95 | 79.62 |
| Announcement Date | 06/08/18 | 27/07/19 | 20/08/20 | 20/07/21 | 14/07/22 | 25/07/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2,381 | 3,207 | 3,070 | 4,320 | 4,866 | 5,275 |
| EBITDA 1 | 200.9 | 341.2 | 293.5 | 440.6 | 481.6 | 531.2 |
| EBIT 1 | 183.1 | 325.1 | 230.9 | 295.4 | 365.3 | 437.2 |
| Operating Margin | 7.69% | 10.14% | 7.52% | 6.84% | 7.51% | 8.29% |
| Earnings before Tax (EBT) 1 | 234.2 | 324 | 191.6 | 385.5 | 391.2 | 474.7 |
| Net income 1 | 165.1 | 233.7 | 143.1 | 284.4 | 305.6 | 361.8 |
| Net margin | 6.94% | 7.29% | 4.66% | 6.58% | 6.28% | 6.86% |
| EPS 2 | 3.295 | 4.663 | 2.855 | 5.675 | 6.099 | 7.220 |
| Free Cash Flow 1 | -61.58 | -143 | 135.9 | -346.6 | 254.7 | 479.1 |
| FCF margin | -2.59% | -4.46% | 4.43% | -8.02% | 5.23% | 9.08% |
| FCF Conversion (EBITDA) | - | - | 46.32% | - | 52.89% | 90.19% |
| FCF Conversion (Net income) | - | - | 95.02% | - | 83.34% | 132.41% |
| Dividend per Share 2 | 1.375 | 1.375 | 1.375 | 1.500 | 1.750 | 2.000 |
| Announcement Date | 06/08/18 | 27/07/19 | 20/08/20 | 20/07/21 | 14/07/22 | 25/07/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 4.63 | - | - |
| Net Cash position 1 | 369 | 115 | 226 | - | 210 | 522 |
| Leverage (Debt/EBITDA) | - | - | - | 0.0105 x | - | - |
| Free Cash Flow 1 | -61.6 | -143 | 136 | -347 | 255 | 479 |
| ROE (net income / shareholders' equity) | 11.4% | 14.9% | 8.75% | 16.1% | 15.1% | 15.9% |
| ROA (Net income/ Total Assets) | 5.75% | 9.04% | 5.09% | 5.6% | 6.72% | 7.27% |
| Assets 1 | 2,871 | 2,584 | 2,809 | 5,075 | 4,549 | 4,979 |
| Book Value Per Share 2 | 29.90 | 32.80 | 32.40 | 38.00 | 42.70 | 48.10 |
| Cash Flow per Share 2 | 0.7600 | 1.450 | 0.3700 | 0.4400 | 0.7600 | 0.3800 |
| Capex 1 | 68.6 | 289 | 356 | 61.5 | 16.1 | 15.5 |
| Capex / Sales | 2.88% | 9.02% | 11.61% | 1.42% | 0.33% | 0.29% |
| Announcement Date | 06/08/18 | 27/07/19 | 20/08/20 | 20/07/21 | 14/07/22 | 25/07/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +68.79% | 145M | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +19.22% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -8.33% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.22% | 5.52B |
- Stock Market
- Equities
- ANUHPHR6 Stock
- Financials Anuh Pharma Limited
